Invisible Forces is a podcast that investigates the unseen influences that drive our spending, our saving and our global economy. 

Hosted by Jefferies' insider Shannon Murphy, season three is all about one invisible force – the alchemy that can turn a series of unlikely events, surprises and setbacks into medicine’s biggest successes.

We’ll hear from biotech industry leaders and our own Jefferies experts about some of the biggest breakthroughs in medical history – and the investments that brought them into reality.

&lt;p&gt;If you had lung cancer, you’d take one kind of drug. If you had liver cancer, you’d take another drug. Makes sense, right? But scientists have found another, more effective, more targeted way to treat cancer — one that you need a code to unlock. In this episode we look at the surprising history and the hopeful future of immunotherapy, and how the genetic code of cancer &lt;i&gt;itself&lt;/i&gt; has been used to find a way to treat the disease.&lt;/p&gt;&lt;p&gt;Featuring:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Neeha Zaidi &lt;/strong&gt;is a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre. &lt;/li&gt;&lt;li&gt;&lt;strong&gt;Mike Yee&lt;/strong&gt; is Jefferies’ managing director and senior biotech analyst&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Neville Sanjana&lt;/strong&gt; is a core faculty member at the New York genome center and also an assistant professor of biology at NYU&lt;/li&gt;&lt;/ul&gt;<br />


Invisible Forces

The Data